Reference number : 236-2018-2019-Q2-00464, amendment number : , agreement type : G, recipient legal name : Marquis-Gravel, Guillaume, recipient country : US, recipient province : nan, recipient city : Durham, recipient postal code : nan, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 120000.0, agreement start date : 2018-07-01, agreement end date : 2020-06-30, description english : Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial "Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long- term Effectiveness (ADAPTABLE)", description french : Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial "Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long- term Effectiveness (ADAPTABLE)", expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada